1. Chabner, B. A.,Cancer: Principles and Practice of Oncology 4th Ed., J.B. LIPPINCOTT Co., Philadelphia, 1993, pp. 325–340.
2. Champagne D. E., Koul, O., Isman, M. B., Scudder, G. G., and Neil Towers, G. H., Biological activity of Limonoids from the Rutales.Phytochemistry, 31, 377–394 (1992).
3. Kim, Y. H., Hwang, B. Y., Kim, S. E., Kim, H. M., Oh, G. T., Kim, H. S., Lee, S. W., Ro, J. S., Lee, K. S., and Lee, J. J., The effector on the morphological change of human breast cancer cell line from the fruits ofMelia toosendan. submitted to J Pharm. Soc. Kor., (1993).
4. Litchfield, J. T., and Wilcoxon, F., Simplified method of evaluating dose-effects experiments.J. Pharmacol. Exp. Ther., 96, 99–113 (1949).
5. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Camphell, H., Mayo, J., and Boyd, M. R., Feasibility of a highflux anti-cancer drug screen using a diverse panel of cultured human tumor cell lines.Journal of the National Cancer Institute, 83(11), 757–766 (1991).